Fcf Advisors LLC Eli Lilly & CO Transaction History

Fcf Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$434.7 - $599.3 $48,251 - $66,522	-111 Reduced 2.66%	4,057 $2.18 Million
Q2 2023 Jul 19, 2023	SELL	$350.74 - $468.98 $495,946 - $663,137	-1,414 Reduced 25.33%	4,168 $1.95 Million
Q1 2023 Apr 19, 2023	SELL	$310.63 - $364.82 $160,906 - $188,976	-518 Reduced 8.49%	5,582 $1.92 Million
Q4 2022 Feb 03, 2023	SELL	$321.55 - $374.67 $43,409 - $50,580	-135 Reduced 2.17%	6,100 $2.23 Million
Q3 2022 Oct 12, 2022	SELL	$296.48 - $337.87 $133,416 - $152,041	-450 Reduced 6.73%	6,235 $2.02 Million
Q2 2022 Jul 20, 2022	SELL	$278.73 - $327.27 $1.34 Million - $1.58 Million	-4,825 Reduced 41.92%	6,685 $2.17 Million
Q1 2022 Apr 28, 2022	BUY	$234.69 - $291.66 $2.7 Million - $3.36 Million	11,510 New	11,510 $3.3 Million
Q3 2019 Oct 09, 2019	SELL	$106.79 - $116.16 $1 Million - $1.09 Million	-9,377 Closed	0 $0
Q2 2019 Jul 08, 2019	SELL	$110.79 - $129.32 $117,991 - $137,725	-1,065 Reduced 10.2%	9,377 $1.04 Million
Q1 2019 Apr 09, 2019	BUY	$111.31 - $131.02 $48,419 - $56,993	435 Added 4.35%	10,442 $1.36 Million
Q4 2018 Jan 15, 2019	BUY	$105.9 - $118.64 $1.06 Million - $1.19 Million	10,007 New	10,007 $1.16 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Fcf Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Fcf Advisors LLC with notifications on news.